Materials
Antimicrobial coating for next generation devices
BioInteractions, a leading UK biomaterial technology company, is announcing the launch of TridAnt, a new coating technology for medical devices, which represents a paradigm shift in infection prevention and protection against a broad range of pathogens.
T
ridAnt incorporates active and passive components to create the first truly non-leaching, effective, safe and durable antimicrobial coating for even the most sensitive medical devices and implants – helping to save lives, and needed time, during medical treatment. The World Health Organisation estimates that healthcare-associated infections (HCAI), especially those caused by antimicrobial- resistant pathogens, are the most frequently occurring adverse event in any healthcare system regardless of available resources.
TridAnt signifi cantly reduces the infection risk of medical procedures.
“Strict hygiene regimes and existing disinfectants have limited efficacy in reducing the risk of infection for prolonged periods of time,” explains Arjun Luthra, commercial director for BioInteractions.
well as enveloped and non-enveloped viruses, including
E.Coli, MRSA, Influenza, Norovirus and SARS-Cov-2. TridAnt is suitable for skin protection as well as most other surfaces including woven and non-woven fabrics including metals (nitinol) as well as polymers (polycarbonate and polyurethanes).”
“For some medical devices like catheters, advanced antimicrobial technology like TridAnt prolongs the active life cycle, not only by killing existing microbes, but also by preventing the formation of new colonies on the treated surface for up to 365 days.”
Arjun Luthra, BioInteractions
“Our TridAnt solution offers a new way to combat infections more effectively, efficiently and for longer. Based on more than three decades of dedicated research and trials, TridAnt is fully compliant with current medical device regulations, has been independently tested to international standards (ISO, EN, PAS), and has been proven to provide monoclonal protection, which kills a broad spectrum of gram- positive and gram-negative bacteria as
One of a kind
The new antimicrobial technology is non- leaching and therefore completely safe to use in all environments and even for implants inside the human body. Its active components target microbes (prokaryotic cells) and has reduced risk to human cells, unlike previous technologies. It is the first known medical device technology to terminate enveloped as well as non- enveloped viruses and gram-positive as
Medical Device Developments /
www.nsmedicaldevices.com
well as gram-negative bacteria, which prevents the formation of biofilms for long- periods of time of up to 365 days. In addition to creating a safe and efficient method to kill microbes long-term, the team behind TridAnt also focuses on creating the best bioengineering method to bond the antimicrobial coating securely to the material of the different medical devices for their life cycle. As a result, TridAnt-coated medical devices are protected with a highly effective and non-leaching shield for the entire lifetime of the device. “TridAnt is an enabling technology that enhances the function of the medical device while being biocompatible with its environment,” continues Luthra. “For some medical devices like catheters, advanced antimicrobial technology like TridAnt prolongs the active life cycle, not only by killing existing microbes, but also by preventing the formation of new colonies on the treated surface for up to 365 days (as well as safe enough to protect skin for up to 48 hours) without any noticeable reduction in efficacy.” TridAnt significantly reduces the infection risk associated with medical procedures and actively reduces the contamination of pathogens within a patient. It is an important addition to the arsenal available to medical professionals in the fight against life threatening infections and secondary complications when operating on patients. This enhances the well-being of a patient when they are in care and allows more effective and efficient procedures for professionals. ●
www.biointeractions.com 85
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128
